Efficacy and Safety of the Imatinib in the Treatment of 73 Gastrointestinal Stromal Tumors

Y. Shi,C. Du,Y. Zhou
DOI: https://doi.org/10.1200/jco.2008.26.15_suppl.21512
IF: 45.3
2008-01-01
Journal of Clinical Oncology
Abstract:21512 Background: To evaluate the efficacy and safety of imatinib in the adjuvant therapy or in the management of metastatic/unresectable GIST in China. Methods: Among total 73 GISTs proved pathologically, 18 cases of them were managed as adjuvant therapy and 55 cases were palliative. All the GIST received oral imatinib at the dose of 400–800mg/d. Results: 18 of total 73 GISTs were managed as adjuvant therapy with oral imatinib at the dose of 400mg/d, therapeutic time ranged 4–13 months (median time 7 months), time of follow-up ranged 4–27 months (median time 8 months), no relapse occurred and all of 18 cases were disease-free. 55 cases were advanced GISTs and received oral imatinib at the dose of 400–800mg/d palliatively and median therapeutic time is 8.5 months. 2 of 55 cases (3.6%) achieved complete response (CR), 20 cases (36.4%) had partial response (PR), 25 cases had stable disease (SD), 5 cases (9.1%) had progression disease (PD) and 3 cases were unable to evaluate because of no measured tumor. The total clinical effective rate (CR+PR+SD) is 85.5%. 6 cases experienced disease progression after PR/SD and 1 of them re-achieved stable disease with increasing the dose to 800mg/d. 22 cases had been followed up for more than one year and the 1-year survival was 93.8% in the palliative group. According to the NCI-CTC 3. 0 standard, the main toxicity we observed included grade I-II edema 47.9%; nausea and vomiting 31.5%; leukopenia 27.4%; liver dysfunction 11.0%; kidney dysfunction 2.7%; fatigue 16.4%; alimentary tract hemorrhage 1.4%; skin rash 1.4%. Conclusions: Imatinib was effective and safe to metastatic/unresectable GIST and its toxicity was acceptable. For the high-risk GIST, imatinib may be used as adjuvant therapy after radical operation. No significant financial relationships to disclose.
What problem does this paper attempt to address?